211 related articles for article (PubMed ID: 14515884)
1. Managing psychotropic drug costs: will formularies work?
Huskamp HA
Health Aff (Millwood); 2003; 22(5):84-96. PubMed ID: 14515884
[TBL] [Abstract][Full Text] [Related]
2. Implications of Part D for mentally ill dual eligibles: a challenge for Medicare.
Morden NE; Garrison LP
Health Aff (Millwood); 2006; 25(2):491-500. PubMed ID: 16522603
[TBL] [Abstract][Full Text] [Related]
3. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
Docherty JP; Browne RA; Farmer M
Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
[TBL] [Abstract][Full Text] [Related]
4. Coverage and prior authorization of psychotropic drugs under Medicare Part D.
Huskamp HA; Stevenson DG; Donohue JM; Newhouse JP; Keating NL
Psychiatr Serv; 2007 Mar; 58(3):308-10. PubMed ID: 17325102
[TBL] [Abstract][Full Text] [Related]
5. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
6. Engaging community mental health stakeholders in pharmacy cost management.
Baker JG
Psychiatr Serv; 2001 May; 52(5):650-3. PubMed ID: 11331800
[TBL] [Abstract][Full Text] [Related]
7. The effect of a three-tier formulary on antidepressant utilization and expenditures.
Hodgkin D; Parks Thomas C; Simoni-Wastila L; Ritter GA; Lee S
J Ment Health Policy Econ; 2008 Jun; 11(2):67-77. PubMed ID: 18509214
[TBL] [Abstract][Full Text] [Related]
8. Medicaid prescription drug coverage: state efforts to control costs.
Gencarelli DM
NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
[TBL] [Abstract][Full Text] [Related]
9. Mental health policy and psychotropic drugs.
Frank RG; Conti RM; Goldman HH
Milbank Q; 2005; 83(2):271-98. PubMed ID: 15960772
[TBL] [Abstract][Full Text] [Related]
10. Choosing drug of choice from restrictive formulary.
Bender KJ
J Clin Psychopharmacol; 1997 Jun; 17(3):145-8. PubMed ID: 9169956
[No Abstract] [Full Text] [Related]
11. Mental health in the Medicare Part D drug benefit: a new regulatory model?
Donohue J
Health Aff (Millwood); 2006; 25(3):707-19. PubMed ID: 16684735
[TBL] [Abstract][Full Text] [Related]
12. Medicare part D and decompensation.
Park JM; Hariprasad R; Park LT
Psychiatr Serv; 2006 May; 57(5):722-3. PubMed ID: 16675773
[No Abstract] [Full Text] [Related]
13. The new medicare drug benefit: formularies and their potential effects on access to medications.
Huskamp HA; Keating NL
J Gen Intern Med; 2005 Jul; 20(7):662-5. PubMed ID: 16050866
[TBL] [Abstract][Full Text] [Related]
14. States' control of prescription drug spending: a heterogeneous approach.
Morden NE; Sullivan SD
Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
[TBL] [Abstract][Full Text] [Related]
15. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
[TBL] [Abstract][Full Text] [Related]
16. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.
Donohue JM; Frank RG
Psychiatr Serv; 2007 Oct; 58(10):1285-91. PubMed ID: 17914004
[TBL] [Abstract][Full Text] [Related]
17. The impact of a national prescription drug formulary on prices, market share, and spending: lessons for Medicare?
Huskamp HA; Epstein AM; Blumenthal D
Health Aff (Millwood); 2003; 22(3):149-58. PubMed ID: 12757279
[TBL] [Abstract][Full Text] [Related]
18. Do open formularies increase access to clinically useful drugs?
Walser BL; Ross-Degnan D; Soumerai SB
Health Aff (Millwood); 1996; 15(3):95-109. PubMed ID: 8854512
[TBL] [Abstract][Full Text] [Related]
19. Do drug formulary policies reflect evidence of value?
Neumann PJ; Lin PJ; Greenberg D; Berger M; Teutsch S; Mansley E; Weinstein MC; Rosen AB
Am J Manag Care; 2006 Jan; 12(1):30-6. PubMed ID: 16402886
[TBL] [Abstract][Full Text] [Related]
20. Drug companies crying foul over Medicaid's formulary push.
Carroll J
Manag Care; 2002 Nov; 11(11):12-4. PubMed ID: 12491852
[No Abstract] [Full Text] [Related]
[Next] [New Search]
